Distinct mechanisms of inhibition of Kv2 potassium channels by tetraethylammonium and RY785
eLife · 2026
DOI: 10.7554/elife.101855 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2026. Verfasst von Shan Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Theoretical Molecular Biophysics Laboratory, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, United States. Hauptthemen laut MEDLINE: Shab Potassium Channels, Tetraethylammonium, Potassium Channel Blockers. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NIH HHS, NIH.
Abstract (Originalsprache)
Voltage-gated K + channels play central roles in human physiology, in health, and disease. A repertoire of inhibitors that are both potent and specific would, therefore, be of great value. RY785 has been described as promising in this regard, as it selectively inhibits channels in the Kv2 subfamily with high potency. Its mechanism of action has not yet been determined at the molecular level, but functional studies indicate it differs from those of less specific inhibitors, such as quaternary-ammonium compounds or aminopyridines. To examine this mechanism at the single-molecule level, we have carried out a series of all-atom molecular dynamics simulations based on the structure of the Kv2.1 channel in the ion-conducting state. The simulations demonstrate both RY785 and tetraethylammonium spontaneously enter the channel interior through the cytoplasmic gate, but with distinct effects. Tetraethylammonium binds to a site adjacent to the selectivity filter, on the pore axis, thus blocking the flow of K + ions. RY785, by contrast, binds to the channel walls, off-axis, and allows K + flow while the gate remains open. This observation indicates RY785 inhibits Kv2.1 by fostering the occlusion of the gate, through a network of hydrophobic interactions therein, explaining why it also modulates the voltage-sensing mechanism of the channel, 3 nanometers away.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Theoretical Molecular Biophysics Laboratory, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, United States.
- Molecular and Cell Biology Graduate Program, Johns Hopkins University, Baltimore, United States.
ORCID-Profile: Esam A Orabi, José D Faraldo-Gómez
Förderung
- NIH HHS
- NIH
Zitieren
APA
Zhang, S., Stix, R., Orabi, E. A., Bernhardt, N., & Faraldo-Gómez, J. D. (2026). Distinct mechanisms of inhibition of Kv2 potassium channels by tetraethylammonium and RY785. eLife. https://doi.org/10.7554/elife.101855
Vancouver
Zhang S, Stix R, Orabi EA, Bernhardt N, Faraldo-Gómez JD. Distinct mechanisms of inhibition of Kv2 potassium channels by tetraethylammonium and RY785. eLife. 2026. doi:10.7554/elife.101855
BibTeX
@article{Zhang2026,
author = {Zhang, Shan and Stix, Robyn and Orabi, Esam A and Bernhardt, Nathan and Faraldo-Gómez, José D},
title = {Distinct mechanisms of inhibition of Kv2 potassium channels by tetraethylammonium and RY785},
journal = {eLife},
year = {2026},
doi = {10.7554/elife.101855}
}
EUVIMED